D. Bouros (Alexandroupolis, Greece), C. Albera (Turin, Italy)
The role of vitamin D3 in the local inflammatory process in sarcoidosis (SA)
A. Kowalska, E. Puscinska, A. Goljan-Geremek, A. Skoczylas, J. Czerniawska, A. Rozy, P. Jagus, J. Chorostowska-Wynimko, D. Górecka (Warsaw, Poland)
|   |
Vitamin D3 and markers of systemic inflammation in sarcoidosis (SA)
A. Kowalska, E. Puscinska, A. Goljan-Geremek, A. Skoczylas, J. Czerniawska, A. Rozy, P. Jagus, J. Chorostowska-Wynimko, D. Górecka (Warsaw, Poland)
| |
Polymorphisms in CCR5 confer susceptibility to Löfgren‘s syndrome and may regulate the immune response
B. Karakaya, C. H. M. van Moorsel, G. T. Rijkers, A. H. M. van der Helm, T. W. J. Huizinga, J. M. M. van den Bosch, J. C. Grutters (Nieuwegein, Leiden, Netherlands)
| |
Chitotriosidase: A sensitive biomarker of sarcoidosis
E. Bargagli, D. Bennett, C. Maggiorelli, M. G. Pieroni, R. M. Refini, M. G. Perari, P. Rottoli (Sienna, Italy)
| |
Mycobacterial heat shock protein 16 kDa, marker of dormant stage of mycobacteria, in precipitated circulating immune complexes in sarcoidosis
A. Dubaniewicz, A. Holownia, M. Singh (Gdank, Bialystok, Poland; Braunschweig, Germany)
| |
Use of discriminant analysis to assess pulmonary functional worsening in patients with sarcoidosis by means of a panel of inflammatory markers
G. Paone, M. Rulli, A. Belli, A. Propati, A. Sbrocca, S. D‘Antonio, A. Sebastiani, G. Puglisi, G. Galluccio, S. Batzella (Rome, Milan, Italy)
|  |
Chronic fatigue in sarcoidosis-in-clinical-remission: Psychological and physical characteristics
I. Korenromp, C. Heijnen, O. Vogels, J. Grutters (Nieuwegein, Utrecht, Netherlands)
| |